Life Science Blog - Marketing Insights

CDMOs streamline pharmaceutical development, offering cost-efficiency, expertise, and agility in producing innovative therapeutics.

Strong, effective B2B marketing is critical for science-driven companies to stand out in increasingly competitive industries. From pharmaceuticals to materials science to medical devices, specialty chemicals, and beyond, you can maximize B2B marketing by following a standard set of best practices.

Biosimilars are similar versions of biologics, which are drugs made from living sources. Here’s everything you need to know about how they’re made, what they treat, and why they’re desirable.

Antibody-Drug Conjugates combine monoclonal antibodies, payloads, and linkers to selectively target cancer cells.

Extractables and leachables are contaminants that may be present in a drug product. These impurities can come from any associated manufacturing or packaging components. The FDA regulates the testing of these impurities. The rise of single-use products and biologics poses new challenges.

Improving manufacturing efficiency through process intensification is becoming increasingly important in biopharmaceutical development.

Clinical trial phases establish the safety, effectiveness, and comparative advantage of a treatment before approval.